SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

Autres langues Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Actions

002399

CNE100000P02

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 29/04/2024			Varia. 5j.	Varia. 1 janv.
9,42 ^CNY	+2,17 %		+5,13 %	-19,69 %

29/04	Shenzhen Hepalink Pharmaceutical Group Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
02/04	Shenzhen Hepalink reçoit l'approbation de la Thaïlande pour Exarane, un médicament contre les caillots sanguins	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane	02/04
Thailand Food and Drug Administration Approves for Sales in the Market of Exarane Produced by Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s Wholly-Owned Subsidiary Shenzhen Techdow Medicine Co., Ltd	02/04
Shenzhen Hepalink Pharmaceutical Widens 2023 Loss as Revenue Drops 24%	01/04
Shenzhen Techdow Medicine Co., Ltd., Wholly-Owned Subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces Exarane Obtains Approval from New Zealand Medicines and Medical Devices Safety Authority	28/03
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces No Final Dividend for the Year Ended 31 December 2023	28/03
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SEHK:9989) dropped from FTSE All-World Index	18/03
Hepalink Pharmaceutical Gets Lifeline from Controlling Shareholder	15/03
Shenzhen Hepalink Forecasts Loss in 2023; Shares Slide 4%	31/01
Shenzhen Hepalink Flags Provisions of Up to 950 Million Yuan; Shares Fall 4%	31/01
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the Period from January 1, 2023 to December 31, 2023	30/01
Hepalink Faces Regulatory Scrutiny After 12 Million Euro Telecom Fraud; Hong Kong Shares Down 3%	16/01
Hepalink Pharma Unit Hit by 11.7 Million Euro Telecom Fraud	15/01
Hepalink Pharma Associate HighTide Therapeutics to Debut in Hong Kong on Friday	18/12
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SZSE:002399) dropped from Shenzhen Stock Exchange Component Index	11/12
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SZSE:002399) dropped from Shenzhen Stock Exchange Component A Share Index	11/12
Hepalink Pharmaceutical's Profit Drops 86% in Q3; Shares Slump 4%	31/10/23
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Hepalink Pharmaceutical's H1 Attributable Profit Plunges on Higher Share of Losses from Associates	31/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Actions

002399

CNE100000P02

Autres langues

Filtres